SUNNYVALE, Calif., Oct. 25, 2022 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), an organization targeted on decreasing the danger of stroke and its devastating impression, at present introduced it would report monetary outcomes for the third quarter 2022 after market shut on Tuesday, November 8th, 2022. Company administration will host a corresponding audio webcast starting at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Those fascinated by listening to the convention name ought to register on-line utilizing this hyperlink. Participants are inspired to register greater than quarter-hour earlier than the beginning of the decision. A reside and replay model of the webcast can be out there at https://investors.silkroadmed.com.
About Silk Road Medical
Silk Road Medical, Inc. (NASDAQ: SILK), is a medical gadget firm situated in Sunnyvale, California, and Plymouth, Minnesota, that’s targeted on decreasing the danger of stroke and its devastating impression. The firm has pioneered a brand new method for the therapy of carotid artery illness referred to as TransCarotid Artery Revascularization (TCAR). TCAR is a clinically confirmed process combining surgical rules of neuroprotection with minimally invasive endovascular strategies to deal with blockages within the carotid artery susceptible to inflicting a stroke. For extra info on how Silk Road Medical is delivering brighter affected person outcomes by brighter scientific pondering, go to www.silkroadmed.com and join on Twitter, LinkedIn and Facebook.
Investor Contact:
Lynn Lewis or Marissa Bych
Gilmartin Group
[email protected]